Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Randomized Controlled Study of High/Low-dosage Rivaroxaban Compared With DAPT After Left Atrial Appendage Occulsion in Patients With Non-valvular Atrial Fibrillation（ESCORT-AF Study(B)）

NCT04135677 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT04135677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04135677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Randomized Controlled Study of High/Low-dosage Rivaroxaban Compared With DAPT After Left Atrial Appendage Occulsion in Patients With Non-valvular Atrial Fibrillation（ESCORT-AF Study(B)）
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 11, 2022
Completion date
October 30, 2024
Enrollment
826 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left atrial appendage thrombosis, stroke, thrombi